There is an increased risk of mortality during the performance of endoscopic procedures, especially during upper gastrointestinal endoscopy procedures in a COVID-19-positive patient, and increased bleeding complications may be attributed to coagulopathy associated with the virus; for its prevention and management, close monitoring of prothrombin time and platelet count are suggested [26]. This evidence concerns the gene F2 and COVID-19.